John T G, Jalan R, Stanley A J, Redhead D N, Sanfey H A, Hayes P C, Garden O J
Scottish Liver Transplant Unit, Royal Infirmary, Edinburgh, UK.
Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1145-9. doi: 10.1097/00042737-199612000-00002.
To investigate the impact of preoperative transjugular intrahepatic portosystemic stent-shunt (TIPSS) on patients undergoing liver transplantation.
A retrospective non-randomized comparative clinical study.
Tertiary referral institution.
PATIENTS, PARTICIPANTS: Twenty-four patients with liver cirrhosis, portal hypertension and gastro-oesophageal varices who underwent liver transplantation.
TIPSS insertion had been performed preoperatively in 12 patients.
Operative dissection times and blood transfusion requirements during liver transplantation. Postoperative complication rate. Cumulative patient and graft survival.
There were no significant differences in outcome measures between patients with and without previous TIPSS insertion with respect to recipient hepatectomy times (mean 192 min (126-280) versus 196 min (145-254)), total operating time (mean 484 min (330-690) versus 486 min (370-580)), intraoperative blood transfusion (mean 11 units (2-29) versus 12 units (2-30)), intraoperative fresh frozen plasma transfusion (mean 9 units (1-16) versus 11 (2-23) units), patient survival (83% versus 92% cumulative 1-year survival), graft survival (80% versus 83% cumulative 1-year survival), or postoperative complication rates.
TIPSS insertion is feasible and relatively safe as a 'bridge to transplantation' in patients who have had a variceal haemorrhage. There is little evidence that preoperative TIPSS insertion directly affects the performance of liver transplantation as TIPSS neither, hinders nor facilitates surgery or post operative survival. Although it is important that the potential hazards of TIPSS extension into the inferior vena cava or superior mesenteric vein be recognized, liver transplant surgeons need not be unduly concerned about the overall impact of TIPSS as it becomes more universally available in the management of variceal haemorrhage.
探讨术前经颈静脉肝内门体分流术(TIPSS)对肝移植患者的影响。
一项回顾性非随机对照临床研究。
三级转诊机构。
患者、参与者:24例肝硬化、门静脉高压和胃食管静脉曲张并接受肝移植的患者。
12例患者术前进行了TIPSS植入。
肝移植术中的手术解剖时间和输血需求。术后并发症发生率。患者和移植物的累积生存率。
术前接受TIPSS植入和未接受TIPSS植入的患者在以下方面的观察指标无显著差异:受体肝切除术时间(平均192分钟(126 - 280)对196分钟(145 - 254))、总手术时间(平均484分钟(330 - 690)对486分钟(370 - 580))、术中输血(平均11单位(2 - 29)对12单位(2 - 30))、术中新鲜冰冻血浆输注(平均9单位(1 - 16)对11(2 - 23)单位)、患者生存率(1年累积生存率83%对92%)、移植物生存率(1年累积生存率80%对83%)或术后并发症发生率。
对于发生过静脉曲张出血的患者,TIPSS植入作为“移植桥梁”是可行且相对安全的。几乎没有证据表明术前TIPSS植入会直接影响肝移植手术,因为TIPSS既不阻碍也不促进手术或术后生存。虽然认识到TIPSS延伸至下腔静脉或肠系膜上静脉的潜在风险很重要,但随着TIPSS在静脉曲张出血管理中更广泛应用,肝移植外科医生不必过度担心其总体影响。